Did DRNA stock beat earnings estimates in the most recent quarter?
Dicerna Pharmaceuticals Inc (DRNA) beat EPS estimates and beat revenue estimates in the most recent quarter.
NASDAQ:DRNA
Past quarterly earnings results for Dicerna Pharmaceuticals Inc (DRNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2021 | -0.22 | -0.47 | 53.46% | 24.14% | 62.954M | 44.657M | 40.97% | 28.79% |
| Q2 2021 | -0.53 | 0.42 | -226.24% | -23.26% | 41.337M | 93.117M | -55.61% | 2.19% |
| Q1 2021 | -0.39 | -0.38 | -3.09% | -25.81% | 47.6M | 47.202M | 0.84% | 39.88% |
| Q4 2020 | -0.49 | -0.03 | -1,672.01% | - | 40.96M | 68.597M | -40.29% | - |
| Q3 2020 | -0.29 | -0.20 | -42.56% | - | 48.88M | 52.53M | -6.95% | - |
| Q2 2020 | -0.43 | 0.10 | -520.31% | - | 40.45M | 63.546M | -36.35% | - |
| Q1 2020 | -0.31 | 0.27 | -214.04% | - | 34.03M | 61.024M | -44.24% | - |
Notes
Dicerna Pharmaceuticals Inc (DRNA) beat EPS estimates and beat revenue estimates in the most recent quarter.